The abstract is read at the publisher; the summary is JClub's.
Sensory neuron-specific silencing of mutant ATXN3 in Avil-Cre; cKI mice significantly ameliorates peripheral nerve abnormalities and DRG splicing dysregulation in SCA3.
- Why it matters: Peripheral neuropathy is common, but its contribution to repeat expansion diseases and the therapeutic target cells in SCA3 are poorly defined, limiting robust preclinical modeling.
- What they did: The study used SCA3 knock-in Atxn3 Q300/Q6 (KI) and Atxn3 -/- knockout (KO) mice with nerve conduction, behavioral assays, peripheral pathology, and bulk RNA sequencing of KI dorsal root ganglia (DRG). It then created a conditional “OFF” SCA3 knock-in (cKI) crossed to Avil-Cre to silence mutant ATXN3 in sensory neurons and repeated phenotyping.
- The result: KI mice showed progressive sensorimotor deficits, peripheral histopathology, and RNA splicing dysregulation, while KO mice had normal peripheral nerve function, implicating toxic gain-of-function from mutant ATXN3. Sensory neuron silencing in Avil-Cre; cKI mice improved peripheral nerve abnormalities and DRG splicing dysregulation, supporting sensory neurons as a therapeutic target and enabling peripheral intervention development in SCA3.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.